Course Information

2nd Annual UCLA Solid Organ Transplant Symposium: Addressing the Organ Shortage, Expanding Access and Bridging Gaps During a Pandemic

Live Virtual Learning

June 18, 2021

Download: [ PDF ]

The UCLA Solid Organ Transplant Symposium is a virtual conference coordinated through UCLA Health Department of Transplant Services; the UCLA Office of Continuing Medical Education and the UCLA Transplant Multi-Disciplinary teams. The goal of this program is to provide a forum for UCLA Transplant multidisciplinary team experts to discuss the organ shortage crisis and explore recent expansion of donor/criteria options that may help attenuate the gap between the supply of and demand for organ donors, while striving for ethical management of a scarce resource, in the midst of the COVID-19 pandemic.

Target Audience

The target audience for this symposium is health care professionals who provide care for patients pre- and post-transplant including: Heart, Lung, Liver, Kidney, Pancreas and Intestinal/Multivisceral transplantation. The symposium content is designed for local community physicians, transplant nurses, transplant nurse coordinators, administrators, nurse practitioners, pharmacists, social workers, dietitians and all members of the transplant team to guide and improve their clinical practice and patient management during all phases of transplantation.

Enrollment

To enroll click here.

*Note: To ensure course material is received before the course begins, early registration is advised. Online registration will close at 11:59 PM on Wednesday, June 16th.

Enrollment after online registration has closed:

  • Option 1: Please call (310) 794 – 2620 between 8:00 AM – 5:00 PM (Pacific Standard Time) by Thursday, June 17th.
  • Option 2: Email us between 8:00 AM – 5:00 PM (Pacific Standard Time) at UCLACME@mednet.ucla.edu by Thursday, June 17th.

Enrollment on the day(s) of the course: Registration will only be accepted between 7:00 AM - 10:00 AM (Pacific Standard Time). Please leave a voicemail with your name, callback number, and the course you’d like to attend. An assistant will return your call  during that timeframe to enroll you in the course.

By Phone

Call (310) 794-2620. We accept American Express, MasterCard, VISA, and Discover cards.

Course Fee

  • $50.00

Refunds

Cancellations must be received in writing by Friday, May 15, 2021 and will be subject to a $25 processing fee. No refunds will be granted after that date. If, for any reason, the course must be cancelled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided.

Course Chairs

Juan C. Alejos, MD
Abbas Ardehali, MD, FACS
Erik Lum, MD, FASN, FNKF
Ali Nsair, MD
Anjay Rastogi, MD, PhD
Sammy Saab, MD, MPH, AGAF, FAASLD, FACG

Transplant Administration

Nanci Flores, RN, MBA
Nick Feduska, Jr., MSHA

Transplant Nurse Managers

Melissa Dunbar Forrest, RN, BSN, CPTC (Kidney)
Melissa A. Moore, RN, BSN, CCTC (Heart/Lung)
Emily Stimpson, RN, MSN, CCTC (Solid Organ Call Team)

Transplant Nurse Coordinators Planning Committee

Oonagh Sankar, RN, MRC, CCTC (Liver)
Rhonda Hutley, BSN, CCTC (Kidney Living Donor)
Jill Strejc, RN, MSN, MS, RD, CCTC (Kidney/Pancreas)
Christine Lee, RN, BSN, CCTC (Kidney/Pancreas)

Course Faculty

Vatche G. Agopian, MD
Associate Professor of Surgery
Director – Dumont-UCLA Liver Cancer Center
Associate Director – General Surgery Residency Program
Liver Transplantation and Hepatobiliary Surgery
Department of Surgery
David Geffen School of Medicine at UCLA

Juan C. Alejos, MD
Clinical Professor
Director, Pediatric Heart Failure/Heart Transplant Program
UCLA Mattel Children’s Hospital
David Geffen School of Medicine at UCLA

Abbas Ardehali, MD, FACS
Professor of Surgery and Medicine
Division of Cardiothoracic Surgery
William E Conner Chair in Cardiothoracic Transplantation
Director, UCLA Heart and Lung Transplantation Program
David Geffen School of Medicine at UCLA

Gina Choi, MD
Assistant Professor of Medicine and Surgery
Associate Program Director, Transplant Hepatology Fellowship
David Geffen School of Medicine at UCLA
Division of Liver and Pancreas Transplantation
Dumont-UCLA Liver Transplant Center
Pfleger Liver Institute

Gabriel M. Danovitch, MD, FRCP (Hon)
John J. Kuiper Chair of Nephrology and Renal Transplantation
Distinguished Professor of Medicine
David Geffen School of Medicine at UCLA
Medical Director, Kidney and Pancreas Transplant Program
Ronald Reagan Medical Center at UCLA

Nick Feduska, Jr., MSHA
Assistant Director, Transplant Services

Deena Goldwater, MD, PhD
Assistant Professor of Medicine
Divisions of Cardiology and Geriatrics
David Geffen School of Medicine at UCLA

Karen Grimley, PhD, MBA, RN, FACHE, NEA-BC
Chief Nursing Executive, UCLA Health Interim Chief Nursing Officer
Ronald Reagan Medical Center at UCLA





 

Fady M. Kaldas MD, FACS
Associate Professor of Surgery
Kelly Lee Tarantello Chair in Integrative Liver Transplantation
Co-Director, Heart-Liver Disease Program
Director, Liver Transplant Service
Director, Transplant & Hepatobiliary Fellowship
Division of Liver and Pancreas Transplantation
David Geffen School of Medicine at UCLA

Marci Knox, LCSW, MPH
Kidney Transplant Inpatient Social Worker

Erik Lum, MD, FASN, FNKF
Medical Director – HLA Incompatible Kidney Transplant Program
Associate Clinical Professor of Medicine
David Geffen School of Medicine at UCLA

Ali Nsair, MD
Medical Director
Heart Transplantation & Mechanical Circulatory Support Device Services
Heart Failure
Interventional Cardiology
Broad Stem Cell Research Center

Anjay Rastogi, MD, PhD
Professor and Clinical Chief, Nephrology
Director, CORE Kidney Programbr> Director, Nephrology Clinical Research Program
Director, PKD Program
Director, Fabry Program
Director, ESRD | Dialysis Program

Sammy Saab, MD, MPH, AGAF, FACG, FAASLD
Medical Director, Pfleger Liver Institute
Medical Director, Adult Liver Transplant Program Chief
Transplant Hepatology Head
Outcomes Research in Hepatology
Professor of Medicine and Surgery
Adjunct Professor of Nursing Professor (Hon)
California Northstate University College of Medicine
Associate Editor for Liver, Journal of Clinical Gastroenterology

David M. Sayah, MD, PhD
Medical Director, Lung and Heart-Lung Transplant Programs
Division of Pulmonary & Critical Care Medicine
David Geffen School of Medicine at UCLA

Joanna Schaenman, MD, PhD, FAST
Associate Professor of Medicine
Division of Infectious Diseases








 

Friday, June 18, 2021

7:30 am (PST) Sign-in and Visit Virtual Exhibits
7:50 am Welcome and Introduction
Karen Grimley, PhD, MBA, RN, FACHE, NEA-BC, & Nick Feduska, Jr., MSHA
8:00 am COVID-19 and Solid Organ Transplantation
Joanna Schaenman, MD, PhD, FAST
8:40 am Updates & Question/Answer Session
LIVER
Moderator: Sammy Saab, MD, MPH, AGAF, FAASLD, FACG
9:00 am New Frontier with Heart-Liver Transplantation
Fady M. Kaldas, MD, FACS
9:15 am Extended Criteria for Liver Transplantation in Hepatocellular Carcinoma
Vatche G. Agopian, MD
9:30 am Covid Pandemic: Patient Management Before and After Liver Transplantation
Sammy Saab, MD, MPH, AGAF, FAASLD, FACG
9:45 am Evolving Indication for Liver Transplantation
Gina Choi, MD
10:00 am Question & Answer
10:10 am Break & Visit Virtual Exhibits
HEART/LUNG
Moderator: Melissa Moore, RN
10:30 am Advances in Heart and Lung Transplantation
Abbas Ardehali, MD, FACS
10:50 am Lung Transplantation in the COVID-19 Era
David M. Sayah, MD, PhD
11:10 am Optimizing Heart Transplant Outcomes and Bridge to Transplant Options and the Impact of the Pandemic
Ali Nsair, MD
11:30 am ABO Incompatible Transplant: The New Frontier
Juan C. Alejos, MD
11:50 am Question & Answer
12:00 pm Break & Visit Virtual Exhibits
KIDNEY
Moderator: Anjay Rastogi, MD
12:20 pm Living Kidney Donation: New Developments
Gabriel M. Danovitch, MD, FRCP (Hon)
12:45 pm Optimizing the Deceased Donor Pool
Erik Lum, MD, FASN, FNKF
1:10 pm Question & Answer
1:20 pm Psychosocial Impact of COVID-19 on Transplant Patients
Marci Knox, LCSW, MPH
1:40 pm Question & Answer
1:50 pm Final Questions & Closing Remarks
Gabriel M. Danovitch, MD, FRCP (Hon)
2:00 pm Adjourn

At the completion of this course, participants should be able to:

  • Discuss evolving indications for liver transplant including liver-heart and extended criteria for hepatocellular carcinoma candidates
  • Explain the challenges and impact of COVID-19 on management of transplant patients
  • Educate patients regarding new donor options that may help decrease the wait for solid organ transplant
  • Identify measures to assist potential pre-transplant patients in overcoming psychosocial barriers to achieve successful transplant outcomes
  • Debate the opportunities and challenges of the current state of organ allocation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved by the AMA for category 1 credit as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.